Concepedia

Shannon N. Westin

SN

Statistics

Publications

170

Citations

10.2K

H-Index

53

Active since

1992

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

Baylor College of Medicine

Dana-Farber Cancer Institute

Oregon Health & Science University

Shannon N. Westin is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and gynecologic oncology.

Publications per year

1992–2025

170

Publications

170

PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring <i>PIK3CA</i> Mutations

Filip Jankú, Jennifer J. Wheler, Shannon N. Westin et al. · Journal of Clinical Oncology · 2012 · 452 citations · Full text

Medicine, Oncology, Pharmacology +17

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

Bradley J. Monk, Christine Parkinson, Myong Cheol Lim et al. · Journal of Clinical Oncology · 2022 · 384 citations · Full text

Medicine, Oncology, Pharmacology +16

Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology–RTOG 1203

Ann H. Klopp, Anamaria R. Yeung, Snehal Deshmukh et al. · Journal of Clinical Oncology · 2018 · 369 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 331 citations · Full text

Medicine, Oncology, Pharmacology +12

AKT Inhibition in Solid Tumors With <i>AKT1</i> Mutations

David M. Hyman, Lillian M. Smyth, Mark T.A. Donoghue et al. · Journal of Clinical Oncology · 2017 · 325 citations

Medicine, Molecular Medicine, Oncology +13

1–5 of 170